COVID-19 Spike-pseudovirus Based Neutralization Assay development

by BellaSmith1
Published: July 27, 2022 (3 weeks ago)
Category
Expires
August 24, 2022

Creative Biolabs, as the leading biomedical CRO in the industry, has successfully helped thousands of researchers complete the development of drugs and vaccines. These achievements are inseparable from our excellent R&D platform and experienced technicians. In the development of COVID-19 drugs and vaccines, one of the most important evaluation indicators is to detect the neutralization ability of the therapeutics to SARS-CoV-2 virus. To this end, we have developed the pseudovirus corresponding to SARS-CoV-2 and provided related pseudovirus-based neutralization test services.

COVID-19 Spike-pseudovirus Based Neutralization Assay development